It is convenient to reinforce the similarities of the results between the review of Cochrane and the present study: that one found that 75 5, in relation to the use of PQ, lacked of preventive effects on the recurrences of vivax and this one reports that it was found that 210 14 produced significantly less recurrences than PQ = 0 and the comparison 210 14 versus 75 5 showed that 210 14 was significantly better.
Conviene reiterar la similitud de los resultados entre la revisión Cochrane y el presente estudio: aquella halló que 75 5, respecto al no uso de PQ, carecía de efecto preventivo de las recurrencias vivax y en este informe se encontró que 210 14 produjo significativamente menos recurrencias que PQ = 0 y la comparación 210 14 versus 75 75 mostró que 210 14 era significativamente mejor.